MoneyWorks4Me

Coral Laboratories - Quaterly Results

14 Feb 2024 Evaluate
The sales declined to Rs. 180.78 millions for the December 2023 quarter as compared to Rs. 247.27 millions during the corresponding quarter last year.Net Profit witnessed a 151.28% growth almost the double from Rs. 8.58 millions to Rs. 21.56  millions  of same quarter last year.Operating profit surged to 35.39 millions from the corresponding previous quarter of 23.48 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 180.78 247.27 -26.89 547.74 666.81 -17.86 781.18 756.11 3.32
Other Income 14.39 15.01 -4.13 45.40 57.34 -20.82 68.95 48.14 43.23
PBIDT 35.39 23.48 50.72 145.31 116.31 24.93 107.07 130.28 -17.82
Interest 0.00 1.08 0.00 0.00 3.20 0.00 3.38 1.41 139.72
PBDT 34.67 22.78 52.19 144.59 113.49 27.40 104.07 138.46 -24.84
Depreciation 4.91 5.00 -1.80 14.73 15.00 -1.80 21.80 19.91 9.49
PBT 29.76 17.78 67.38 129.86 98.49 31.85 82.27 118.55 -30.60
TAX 8.20 9.20 -10.87 29.85 25.10 18.92 17.81 28.10 -36.62
Deferred Tax 0.20 0.20 0.00 0.60 0.60 0.00 -0.39 0.60 -165.00
PAT 21.56 8.58 151.28 100.01 73.39 36.27 64.46 90.45 -28.73
Equity 35.73 35.73 0.00 35.73 35.73 0.00 35.73 35.73 0.00
PBIDTM(%) 19.58 9.50 106.16 26.53 17.44 52.09 13.71 17.23 -20.45
Peers
Company Name CMP
Sun Pharma. Inds. 1850.10
Dr. Reddys Labs. 1201.85
Cipla 1400.20
Lupin 2095.40
Zydus Lifesciences 1187.95
View more..